메뉴 건너뛰기




Volumn 20, Issue 6, 2010, Pages 1083-1087

Editorial: Adaptive designs: Appealing in development of therapeutics, and where do controversies lie?

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE DESIGN; CLINICAL RESEARCH; DRUG DESIGN; DRUG DEVELOPMENT; EDITORIAL; HUMAN; METHODOLOGY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYSTEMATIC ERROR;

EID: 78249276194     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543406.2010.514461     Document Type: Editorial
Times cited : (8)

References (25)
  • 2
    • 0002020527 scopus 로고
    • Multistage testing with adaptive designs (with discussion)
    • Bauer, P. (1989). Multistage testing with adaptive designs (with discussion). Biometrie und Informatik in Medizin and Biologie 20:130-148.
    • (1989) Biometrie und Informatik in Medizin and Biologie , vol.20 , pp. 130-148
    • Bauer, P.1
  • 3
    • 0028619850 scopus 로고
    • Evaluation of experiments with adaptive interim analysis
    • Bauer, P., Kohne, K. (1994). Evaluation of experiments with adaptive interim analysis. Biometrics 50:1029-1041.
    • (1994) Biometrics , vol.50 , pp. 1029-1041
    • Bauer, P.1    Kohne, K.2
  • 4
    • 78249241795 scopus 로고    scopus 로고
    • Comments on the draft guidance on "adaptive design clinical trials for drugs and biologics" of the U. S. Food and Drug Administration
    • Brannath, W., Burger, H. U., Glim, E., Stallard, N., Vandemeulebroecke, M., Wassmer, G. (2010). Comments on the draft guidance on "adaptive design clinical trials for drugs and biologics" of the U. S. Food and Drug Administration. Journal of Biopharmaceutical Statistics 20 (6):1125-1131.
    • (2010) Journal of Biopharmaceutical Statistics , vol.20 , Issue.6 , pp. 1125-1131
    • Brannath, W.1    Burger, H.U.2    Glim, E.3    Stallard, N.4    Vandemeulebroecke, M.5    Wassmer, G.6
  • 5
    • 33646260128 scopus 로고    scopus 로고
    • Are flexible designs sound?
    • Burman, C. F., Sonnesson, C. (2006). Are flexible designs sound? Biometrics 62:664-683.
    • (2006) Biometrics , vol.62 , pp. 664-683
    • Burman, C.F.1    Sonnesson, C.2
  • 6
    • 78249258726 scopus 로고    scopus 로고
    • On the flexibility of adaptive designs and criteria for choosing a good one-A discussion of FDA draft guidance
    • Cheng, B., Chow, S. C. (2010). On the flexibility of adaptive designs and criteria for choosing a good one-A discussion of FDA draft guidance. Journal of Biopharmaceutical Statistics 20 (6):1171-1177.
    • (2010) Journal of Biopharmaceutical Statistics , vol.20 , Issue.6 , pp. 1171-1177
    • Cheng, B.1    Chow, S.C.2
  • 7
    • 78249281982 scopus 로고    scopus 로고
    • FDA draft guidance on adaptive design clinical trials: Pfizer's perspective
    • Chuang-Stein, C., Beltangady, M. (2010). FDA draft guidance on adaptive design clinical trials: Pfizer's perspective. Journal of Biopharmaceutical Statistics 20 (6):1143-1149.
    • (2010) Journal of Biopharmaceutical Statistics , vol.20 , Issue.6 , pp. 1143-1149
    • Chuang-Stein, C.1    Beltangady, M.2
  • 9
    • 0027566177 scopus 로고
    • Ellenberg, S. S., Geller, N., Simon, R., Yusuf, S., eds, Bethesda, Maryland, USA, January 27-28, Statistics in Medicine
    • Ellenberg, S. S., Geller, N., Simon, R., Yusuf, S., eds. (1993). Proceedings of "Practical Issues in data monitoring of clinical trials", Bethesda, Maryland, USA, January 27-28, 1992. Statistics in Medicine 12:415-646.
    • (1992) Proceedings of "Practical Issues in Data Monitoring of Clinical Trials" , vol.12 , pp. 415-646
  • 11
    • 79956105768 scopus 로고    scopus 로고
    • Flexible design clinical trial methodology in regulatory applications
    • doi: 10.1002/sim.4021
    • Hung, H. M. J., Wang, S. J., O'Neill, R. T. (2010). Flexible design clinical trial methodology in regulatory applications. Statistics in Medicine (www.interscience.wiley.com) doi: 10.1002/sim.4021.
    • (2010) Statistics in Medicine
    • Hung, H.M.J.1    Wang, S.J.2    O'Neill, R.T.3
  • 12
    • 0037473229 scopus 로고    scopus 로고
    • Mid-course sample size modification in clinical trials
    • Jennison, C., Turnbull, B. W. (2003). Mid-course sample size modification in clinical trials. Statistics in Medicine 22:971-993.
    • (2003) Statistics in Medicine , vol.22 , pp. 971-993
    • Jennison, C.1    Turnbull, B.W.2
  • 13
    • 4344665155 scopus 로고    scopus 로고
    • A general statistical principle for changing a design any time during the course of a trial
    • Müller, H.-H., Schäfer, H. (2004). A general statistical principle for changing a design any time during the course of a trial. Statistics in Medicine 23:2497-2508.
    • (2004) Statistics in Medicine , vol.23 , pp. 2497-2508
    • Müller, H.-H.1    Schäfer, H.2
  • 15
    • 0000537133 scopus 로고
    • A two-sample test for a linear hypothesis whose power is independent of the variance
    • Stein, C. (1945). A two-sample test for a linear hypothesis whose power is independent of the variance. Annals of Mathematical Statistics 16:243-258.
    • (1945) Annals of Mathematical Statistics , vol.16 , pp. 243-258
    • Stein, C.1
  • 16
    • 1842826262 scopus 로고    scopus 로고
    • On the inefficiency of the adaptive design for monitoring clinical trials
    • Tsiatis, A. A., Mehta, C. R. (2003). On the inefficiency of the adaptive design for monitoring clinical trials. Biometrika 90:367-378.
    • (2003) Biometrika , vol.90 , pp. 367-378
    • Tsiatis, A.A.1    Mehta, C.R.2
  • 17
    • 0003577283 scopus 로고    scopus 로고
    • U. S. Food and Drug Administration, 21CFR314.126. Food and Drug Administration, Health Human Services. Available at
    • U. S. Food and Drug Administration. (2002). Code of Federal Regulation, 21CFR314.126. Food and Drug Administration, Health Human Services. Available at http://edocket.access.gpo.gov/cfr-2002/aprqtr/21cfr314.126.htm
    • (2002) Code of Federal Regulation
  • 18
    • 77954875817 scopus 로고    scopus 로고
    • U. S. Food and Drug Administration, Released on February 25, 2010, for public comments
    • U. S. Food and Drug Administration. (2010). Draft Guidance for Industry on Adaptive Design Clinical Trials for Drugs and Biologics. Released on February 25, 2010, for public comments. www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatory-Information/Guidances/UCM201790.pdf
    • (2010) Draft Guidance for Industry on Adaptive Design Clinical Trials for Drugs and Biologics
  • 19
    • 78249287831 scopus 로고    scopus 로고
    • Perspectives on the use of adaptive designs in clinical trials. Part I. Statistical considerations and issues
    • Wang, S. J. (2010). Perspectives on the use of adaptive designs in clinical trials. Part I. Statistical considerations and issues. Journal of Biopharmaceutical Statistics 20 (6):1090-1097.
    • (2010) Journal of Biopharmaceutical Statistics , vol.20 , Issue.6 , pp. 1090-1097
    • Wang, S.J.1
  • 20
    • 78249265451 scopus 로고    scopus 로고
    • Impacts of type I error rate with inappropriate use of learn for confirm in adaptive designs
    • accepted for publication
    • Wang, S. J., Hung, H. M. J., O'Neill, R. T. (2010a). Impacts of type I error rate with inappropriate use of learn for confirm in adaptive designs. Biometrical Journal Special Issue (accepted for publication).
    • (2010) Biometrical Journal Special Issue
    • Wang, S.J.1    Hung, H.M.J.2    O'Neill, R.T.3
  • 21
    • 78249254692 scopus 로고    scopus 로고
    • Adaptive design clinical trials in CNS drug development
    • Available at:, last accessed October 19, 2010
    • Wang, S. J., Hung, H. M. J., O'Neill, R. T. (2010b). Adaptive design clinical trials in CNS drug development. European Neuropsychopharmacology Journal. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20933373 (last accessed October 19, 2010).
    • (2010) European Neuropsychopharmacology Journal
    • Wang, S.J.1    Hung, H.M.J.2    O'Neill, R.T.3
  • 23
    • 78249263210 scopus 로고    scopus 로고
    • Comments on the FDA draft guidance on adaptive designs
    • Wittes, J. (2010). Comments on the FDA draft guidance on adaptive designs. Journal of Biopharmaceutical Statistics 20 (6):1166-1170.
    • (2010) Journal of Biopharmaceutical Statistics , vol.20 , Issue.6 , pp. 1166-1170
    • Wittes, J.1
  • 24
    • 0024994537 scopus 로고
    • The role of internal pilot studies in increasing the efficiency of clinical trials
    • Wittes, J., Brittan, E. (1990). The role of internal pilot studies in increasing the efficiency of clinical trials. Statistics in Medicine 9:65-72.
    • (1990) Statistics in Medicine , vol.9 , pp. 65-72
    • Wittes, J.1    Brittan, E.2
  • 25
    • 34247981226 scopus 로고
    • Play the winner rule and the controlled clinical trials
    • Zelen, M. (1969). Play the winner rule and the controlled clinical trials. Journal of American Statistical Association 64:131-146.
    • (1969) Journal of American Statistical Association , vol.64 , pp. 131-146
    • Zelen, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.